Fjarde AP Fonden Fourth Swedish National Pension Fund Raises Stock Holdings in HCA Healthcare, Inc. $HCA

Fjarde AP Fonden Fourth Swedish National Pension Fund boosted its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA) by 59.0% in the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 67,539 shares of the company’s stock after acquiring an additional 25,070 shares during the quarter. Fjarde AP Fonden Fourth Swedish National Pension Fund’s holdings in HCA Healthcare were worth $31,962,000 as of its most recent SEC filing.

Other hedge funds have also recently made changes to their positions in the company. State Street Corp lifted its holdings in HCA Healthcare by 1.0% during the 4th quarter. State Street Corp now owns 7,566,643 shares of the company’s stock valued at $3,532,563,000 after buying an additional 76,039 shares in the last quarter. Capital World Investors raised its stake in shares of HCA Healthcare by 0.8% during the fourth quarter. Capital World Investors now owns 4,999,422 shares of the company’s stock valued at $2,334,040,000 after acquiring an additional 40,086 shares in the last quarter. Geode Capital Management LLC grew its stake in HCA Healthcare by 0.4% in the fourth quarter. Geode Capital Management LLC now owns 3,663,705 shares of the company’s stock worth $1,702,738,000 after purchasing an additional 13,565 shares in the last quarter. Norges Bank bought a new stake in HCA Healthcare during the 4th quarter valued at $1,262,513,000. Finally, Arrowstreet Capital Limited Partnership grew its position in shares of HCA Healthcare by 11.9% during the 4th quarter. Arrowstreet Capital Limited Partnership now owns 2,311,112 shares of the company’s stock worth $1,078,966,000 after buying an additional 245,887 shares in the last quarter. 62.73% of the stock is currently owned by institutional investors.

HCA Healthcare Trading Up 4.3%

Shares of HCA stock opened at $409.99 on Friday. The company has a market cap of $90.95 billion, a PE ratio of 14.10, a PEG ratio of 1.25 and a beta of 1.12. HCA Healthcare, Inc. has a 12-month low of $330.00 and a 12-month high of $556.52. The business’s fifty day simple moving average is $401.89 and its 200-day simple moving average is $462.80.

HCA Healthcare (NYSE:HCA) last announced its earnings results on Friday, April 24th. The company reported $7.15 earnings per share for the quarter, missing the consensus estimate of $7.19 by ($0.04). The business had revenue of $19.11 billion for the quarter, compared to analysts’ expectations of $19.09 billion. HCA Healthcare had a negative return on equity of 295.93% and a net margin of 8.89%.The firm’s quarterly revenue was up 4.3% compared to the same quarter last year. During the same quarter last year, the firm earned $6.45 earnings per share. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. On average, equities analysts forecast that HCA Healthcare, Inc. will post 30.07 earnings per share for the current year.

HCA Healthcare Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Tuesday, June 30th. Investors of record on Tuesday, June 16th were paid a $0.78 dividend. The ex-dividend date was Tuesday, June 16th. This represents a $3.12 dividend on an annualized basis and a yield of 0.8%. HCA Healthcare’s dividend payout ratio (DPR) is 10.73%.

Analysts Set New Price Targets

Several research analysts have issued reports on HCA shares. JPMorgan Chase & Co. dropped their target price on shares of HCA Healthcare from $535.00 to $490.00 and set a “neutral” rating on the stock in a report on Tuesday, May 19th. Stephens cut their price objective on shares of HCA Healthcare from $560.00 to $530.00 and set an “overweight” rating on the stock in a report on Monday, April 27th. Truist Financial set a $413.00 target price on HCA Healthcare in a report on Thursday, June 4th. Deutsche Bank Aktiengesellschaft reduced their price target on HCA Healthcare from $558.00 to $540.00 and set a “buy” rating for the company in a research report on Tuesday, April 28th. Finally, Oppenheimer dropped their price objective on HCA Healthcare from $540.00 to $520.00 and set an “outperform” rating on the stock in a research report on Monday, April 27th. Fifteen research analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $503.00.

About HCA Healthcare

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.